The EU European Union (European Union )-JAV core mission is delivering and sharing of concrete tools for stronger national responses to vaccination challenges. The EU‐JAV aims to improve health through advancing long‐lasting European cooperation against vaccine‐preventable diseases. 

EU European Union (European Union )-JAV brings together the European Commission, health ministries, international policymakers and organisations, institutes, universities from 20 countries and a wide range of stakeholders, including civil society and manufacturers’ representatives, working on vaccination policy and health services. The three-year project will run until 31 July 2021. 

European citizens and vaccination

Immunisation is one of the greatest biomedical and public health success stories of the 20th century. The World Health Organization (WHO) has estimated vaccination saves 1 to 3 million lives worldwide every year. Yet, suboptimal uptake of recommended immunisations has increased over the past two decades and has resulted in the re‐emergence of infectious diseases such as measles on the European continent. Infectious diseases have no concept of borders.  Close collaboration and coordination at EU level are critical to prevent cross-border health threats and epidemics.

Objectives

• Monitor more accurately vaccination coverage
• Ensure that everybody in the European Union has access to vaccination
• Improve forecasting of vaccine stocks and systems for the prevention of shortages
• Set priorities for research and development on vaccination
• Enhance the public confidence in vaccination

Funding

 EU-JAV has received co-funding from the European Union’s Health Programme under Grant Agreement no. 801495.